International Patent: METHODS OF TREATING CANCER USING SRC KINASE INHIBITORS

GENEVA, Oct. 30 -- NUVECTIS PHARMA, INC. filed a patent application (US2026/024656) for “METHODS OF TREATING CANCER USING SRC KINASE INHIBITORS”. With publication no. WO/2026/226638, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/519

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....